NFGH
VINC

Nan Fung Group Holdings’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Nan Fung Group Holdings’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-553
Closed -$113K – 59
2021
Q4 		$113K Buy
+553
New +$138K 0.03% 54

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nan Fung Group Holdings's VINC Position: Q1 2022 in Review

Nan Fung Group Holdings sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2022, closing a stake of 553 shares — an estimated $113K sold.

Nan Fung Group Holdings first reported a position in VINC in Q4 2021 and held it in 1 quarter. The position peaked at $113K in Q4 2021. 67 funds tracked by Wall St. Rank hold VINC as of Q1 2022.

  • Nan Fung Group Holdings reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 553 Vincerx Pharma, Inc. Common Stock shares in Q1 2022, an estimated $113K.
  • Nan Fung Group Holdings first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Nan Fung Group Holdings's Vincerx Pharma, Inc. Common Stock position peaked at $113K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2022.

Based on Nan Fung Group Holdings's 13F filing for Q1 2022, filed 13 May 2022.